PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors
Submitted: 20 March 2024
Accepted: 19 June 2024
Published: 5 November 2024
Accepted: 19 June 2024
Abstract Views: 8
PDF: 4
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- L. Olivieri, C. Salvarani, F. Cantini, L. Punzi, M. Matucci Cerinic, Recommendations for starting anti TNF-α in patients with ankylosing spondylitis , Reumatismo: Vol. 55 No. 4 (2003)
- S. Grazzini, R. Terribili, E. Conticini, S. Bartalini, L. Cantarini, B. Frediani, Cervical myelopathy as an atypical presentation of antineutrophil cytoplasmic antibody-associated vasculitis in a patient affected by silicosis: a case report and literature overview , Reumatismo: Early Access
- L. Punzi, M.A. Cimmino, L. Frizziero, V. Gerloni, W. Grassi, V. Modena, C. Montecucco, R. Ramonda, F. Schiavon, A. Spadaro, F. Trotta, Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis , Reumatismo: Vol. 59 No. 3 (2007)
- C.A. Scirè, R. Caporali, C. Perotti, C. Montecucco, Plasma procalcitonin in rheumatic diseases , Reumatismo: Vol. 55 No. 2 (2003)
- D.A. Herrera-vanOostdam, E. Esparza-Ibarra, R. Ramírez-Sandoval, V. Ortíz, J.J. Bollain-y-Goitia, E. Avalos-Diaz, R. Herrera-Esparza, Apoptosis and necrosis increase antigenicity of proteins recognized by antinuclear antibodies , Reumatismo: Vol. 56 No. 3 (2004)
- S. Adami, P. Bartolazzi, M.L. Brandi, A. Falchetti, P. Filipponi, S. Gonnelli, G. Bianchi, G.C. Isaia, R. Nuti, Italian guidelines for the diagnosis and treatment of Paget’s disease of bone , Reumatismo: Vol. 59 No. 2 (2007)
- G. Pasero, P. Marson, A short history of anti-rheumatic therapy. III. Non steroidal anti-inflammatory drugs , Reumatismo: Vol. 62 No. 3 (2010)
- G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero, Safety of lornoxicam in G-6-PDH deficiency , Reumatismo: Vol. 55 No. 1 (2003)
- V. Bruzzese, C. Marrese, P. Scolieri, J. Pepe, Psoriatic spondyloarthritis and Sjögren syndrome: a casual association? , Reumatismo: Vol. 72 No. 3 (2020)
- M. Amatruda, N.S. Carucci, C. Fede, G. Conti, Subclinical TRAPS treated with canakinumab , Reumatismo: Vol. 73 No. 2 (2021)
<< < 71 72 73 74 75 76 77 78 79 > >>
You may also start an advanced similarity search for this article.